157 related articles for article (PubMed ID: 38430648)
1. Research progress of dydrogesterone in the treatment of endometriosis.
Tang W; Zhu X; Bian L; Zhang B
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():120-125. PubMed ID: 38430648
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.
Reis FM; Coutinho LM; Vannuccini S; Batteux F; Chapron C; Petraglia F
Hum Reprod Update; 2020 Jun; 26(4):565-585. PubMed ID: 32412587
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Liang B; Wu L; Xu H; Cheung CW; Fung WY; Wong SW; Wang CC
Reprod Biol Endocrinol; 2018 Apr; 16(1):32. PubMed ID: 29615065
[TBL] [Abstract][Full Text] [Related]
4. Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis.
Peng C; Huang Y; Zhou Y
Arch Gynecol Obstet; 2021 Jul; 304(1):231-252. PubMed ID: 33398505
[TBL] [Abstract][Full Text] [Related]
5. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
6. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone.
Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Mizuuchi M; Moriwaka O; Kamiya H
Reprod Biol; 2021 Mar; 21(1):100470. PubMed ID: 33333410
[TBL] [Abstract][Full Text] [Related]
7. The place of dydrogesterone in the treatment of endometriosis and adenomyosis.
Schweppe KW
Maturitas; 2009 Dec; 65 Suppl 1():S23-7. PubMed ID: 19945806
[TBL] [Abstract][Full Text] [Related]
8. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
Schindler AE
Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
[TBL] [Abstract][Full Text] [Related]
9. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
[TBL] [Abstract][Full Text] [Related]
10. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
[TBL] [Abstract][Full Text] [Related]
11. Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins.
Beranič N; Brožič P; Brus B; Sosič I; Gobec S; Lanišnik Rižner T
J Steroid Biochem Mol Biol; 2012 May; 130(1-2):16-25. PubMed ID: 22245609
[TBL] [Abstract][Full Text] [Related]
12. [Effects of progesterone and progestin on expression of regulated on activation, normal T cell expressed and secreted in eutopic endometrium from patients with endometriosis].
Deng S; Dai Y; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L; Tan XJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):257-61. PubMed ID: 17536280
[TBL] [Abstract][Full Text] [Related]
13. The effect of dydrogesterone on sexual function in endometriosis.
Yalçın Bahat P; Yücel B; Yuksel Ozgor B; Kadiroğulları P; Topbas Selçuki NF; Çakmak K; Üreyen Özdemir E
J Obstet Gynaecol; 2022 Jul; 42(5):1276-1279. PubMed ID: 34581254
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-progestins and progestins for the management of endometriosis.
Vercellini P; Buggio L; Berlanda N; Barbara G; Somigliana E; Bosari S
Fertil Steril; 2016 Dec; 106(7):1552-1571.e2. PubMed ID: 27817837
[TBL] [Abstract][Full Text] [Related]
15. Indications for therapy with progestational agents.
Darragh A
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
[No Abstract] [Full Text] [Related]
16. Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis.
Barbosa MWP; Valadares NPB; Barbosa ACP; Amaral AS; Iglesias JR; Nastri CO; Martins WP; Nakagawa HM
JBRA Assist Reprod; 2018 Jun; 22(2):148-156. PubMed ID: 29488367
[TBL] [Abstract][Full Text] [Related]
17. Progestin therapy in endometriosis.
Gezer A; Oral E
Womens Health (Lond); 2015 Aug; 11(5):643-52. PubMed ID: 26389558
[TBL] [Abstract][Full Text] [Related]
18. Dydrogesterone as an Option in the Medical Treatment of Endometriosis: A Brief Comment.
Carvalho BR
Rev Bras Ginecol Obstet; 2022 Aug; 44(8):802-803. PubMed ID: 35839819
[No Abstract] [Full Text] [Related]
19. Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line.
Beranič N; Rižner TL
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):303-10. PubMed ID: 22878119
[TBL] [Abstract][Full Text] [Related]
20. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
